Supply Chain Resource Council Reports
The Supply Chain Resource Council (SCRC) is comprised of over 90 supply chain and health care leaders from across the health care field.
These leaders meet with the goal of understanding the extent and impact supply shortages and disruptions are having within the hospital and patient care settings, as well as a capturing and documenting solutions to these challenges.
Information collected during these calls is drafted into a report and shared with AHA, AHRMM and Professional Management Group (PMG) senior leaders, the White House Response Team, various Federal Agencies and the broader health care field.
2024 SCRC Reports
November 2024 Report
Primary topics discussed this month were the Baxter IV Fluid shortage and the BD BACTECTM situation. Raw material constraints impacting availability of Baxter/Welch Allyn blood pressure cuffs and several situations currently being monitored round out our report for this month.
September 2024 Report
Angels for Change presented to the Council this month. Laura Bray, Chief Change Maker shared the non-profit, volunteer supported organization’s mission to end drug shortages through advocacy, awareness and a resilient supply chain. AHRMM and Angels for Change have agreed to information sharing and exploring collaboration opportunities.
July 2024 Report
Council members addressed the BD Bactec Blood Culture Bottle shortage and held follow-up talks with BD and the FDA. Other topics included plastic syringe and reagent shortages, with updates on NIOSH respirator decisions.
June 2024 Report
Council members addressed FDA communications on plastic syringes from China, ongoing recalls related to the Nurse Assist LLC Class I recall, and continued inventory challenges with MedGyn tubing and CSF Drainage systems.
May 2024 Report
Council members discussed the impact of plastic syringe recalls, sourcing issues with Integra Craniotomy Kits and the FDA’s guidance on Getinge IABP systems. Hurricane preparedness and helium inventory were also covered, with a post-meeting update on Champak respirators.
March/April 2024 Report
Council members discussed the expansion of kit manufacturer recalls affected by the Nurse Assist, LLC Class I recall of sterile water and saline, as well as adverse events associated with the BD Insyte Autoguard Retractable Syringes.
February 2024 Report
The Council covered a number of new topics including the 3M spin-off of the independent health care company Solventum, Philips Consent Decree regarding their BiPAP, CPAP and select ventilators, and the CDRH release of its Critical Medical Device List - an action under Executive Order 14001 on a Sustainable Public Health Supply Chain.